Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enfamil LIPIL

This article was originally published in The Tan Sheet

Executive Summary

Mead Johnson's DHA-, ARA-fortified infant formula is now available, BMS subsidiary announces March 7. Labeling states formula "provides a blend of DHA and ARA nutrients found in breast milk [which] are important building blocks for a baby's brain and eyes. Closest formula to breast milk ever." 32-oz ready-to-use liquid sells for about $5.69...

You may also be interested in...



U.S. Formula Industry Poorly Conveys Breast Milk Benefits – WHO Report

Infant formula labeling does not adequately warn consumers about the potential health problems and consequences associated with formula use, according to a recent report

US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios

Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.

FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says

The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093723

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel